IMP3 and serous adenocarcinoma: IMP3, PTEN, p53, and beta-catenin were detected in 17% versus 100%, 28% versus 90%, 56% versus 84%, and 28% versus 0% of grade 3 endometrioid carcinomas versus serous carcinomas, respectively 23.